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Abstract
The specific binding of transcription factors (TF) determines in a large part the 
connectivity of gene regulatory networks as well as the quantitative level of gene 
expression. A multiplicity of both experimental and computational methods is currently 
used to discover and characterize the underlying TF-DNA interactions. Experimental 
methods can be further subdivided into in vitro- and in vivo-based approaches, each 
accenting different aspects of TF binding events. In this review we summarize the 
flexibility and performance of a selection of both types of experimental methods. In 
conclusion, we argue that a serial combination of methods with different throughput and 
information content constitutes an optimal experimental strategy.
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Introduction
The coordinated expression of genes drives a majority of cellular processes. This 
coordination is in part regulated by interactions between proteins, called transcription 
factors (TF) and sequence-specific DNA elements, called TF binding sites (TFBS). 
Transcriptional regulation is not an isolated process, but is rather embedded in a highly 
interconnected gene regulatory network (GRN) consisting of hundreds of TFs, their 
target promoters and co-regulators (up to 10% of the human ORF-coding genome 
codes for TFs)[1]. TF binding and function is regulated on several levels. The first, and 
most fundamental order of regulation is achieved by the preferential binding of a 
transcription factor to specific DNA sequences [2]. Higher orders of regulation are 
accomplished by post-translational modifications of TF domains or binding of co-
regulators. These modifications in turn can modulate the activity and/or cellular location 
of a transcription factor [3, 4]. 
It is the specific binding of transcription factors that determines in large part the 
connectivity of gene regulatory networks (GRNs) as well as the quantitative level of 
gene expression [5]. Genetic variations in TFBS are frequently associated with 
differences in transcription among individuals, highlighting the necessity of precise 
characterization [6]. Thus, in-depth characterization of TF-TFBS interactions on a 
genome-wide level is pivotal to our understanding of transcriptional regulation. Any 
comprehensive characterization of GRNs must include TF-DNA binding specificities as 
well as the higher-order modes of regulation such as protein modifications and protein-
protein interactions [7].
Numerous methods, both experimental and computational, exist that allow one 
to discover and comprehensively characterize the specificity by which transcription 
factors interact with cognate DNA elements. In this review we summarize a selection of 
experimental methods primarily focusing on the flexibility and performance of methods 
for determining transcription factor-DNA specificities. Within the field of experimental 
transcription factor biology, two fundamentally different kinds of approaches are used 
to characterize TF interactions: in vitro- and in vivo-based methods. 
In vitro methods generally aim to identify either TF consensus binding sites [8], 
binding energy landscapes [9] or the biophysical parameters governing these binding 
events [10]. In vivo-based methods recover information on TF consensus binding sites 
as well as the biological context of sequence-specific interactions. Experimental 
methods can be further subdivided into methods that provide qualitative or quantitative 
data, with a majority of methods falling in the former category (Figure 1; Table 1). To 
express these differences more explicit we refer to data type as a qualifier to distinguish 
qualitative, semi-quantitative, quantitative, and kinetic data of TF-DNA interactions 
(Table 1, indicated as “+” to “++++”, respectively). 
We refer the reader to excellent reviews [11-14] for a comprehensive overview 
of in silico methods, which generally rely on conservation of TFBS, either amongst a 
set of known co-regulated genes, or within homologous promoters of closely related 
species. The corresponding transcription factor is generally inferred from a priori 
information if it isn’t known already. We also refer the readers who are interested in the 
use and performance of “one-hybrid” screens to the following in-depth reviews [15, 
16]. 
We argue that a combination of several in vitro and in vivo methods is currently 
indispensable to our understanding of transcriptional regulation. Significant 
advancement in quantitative characterization of genome-wide protein-DNA interactions 
in space and time is required before it will be possible to accomplish a major goal in 
transcriptional regulation: the quantitative prediction of GRNs.
Methods to elucidate TF-DNA interactions
Traditionally TFBS have been mapped and characterized in vitro and in vivo using 
electrophoretic mobility shift assays (EMSA)[17, 18] and promoter deletion analysis 
coupled to a reporter assay (e.g. beta-galactosidase)[19], respectively. In many cases 
these classical approaches don’t meet the throughput demands required for a systematic 
characterization of TF – DNA interactions. The genome-wide characterization of TF 
binding profiles only became feasible with the advent of microarray-based methods [20, 
21]. To date, several high-throughput approaches have been developed, including in 
vivo based ChIP-chip and ChIP-seq methods [20-25] and in vitro methods based on 
binding site enrichment [26, 27], DNA microarrays [28-32], or microfluidic devices [9, 
10, 33, 34].
In vitro methods
The first in vitro implementation to determine de novo TF binding sites was developed 
more than two decades ago. Systematic evolution of ligands by exponential enrichment 
(SELEX) is based on incubating a purified TF with a pool of random DNA oligos. TF 
bound oligos are selected, amplified by PCR, and re-incubated with the TF so that 
repeated rounds of selection identifies high-affinity binders, or the TF’s consensus 
TFBS [8, 35, 36]. SELEX was one of the first approaches that could determine the 
consensus binding site of a transcription factor without prior information. Yet the ability 
to accurately determine the consensus binding site is simultaneously a drawback of 
SELEX in that only few high-affinity binding sites are selected and amplified, which is 
insufficient to accurately and comprehensively capture the non-linear relationship 
between sequence composition and binding affinity of TFBS (Figure 2A)[27, 37]. 
To overcome this limitation, in vitro selection was recently coupled to massive 
parallel sequencing approaches [26, 27]. Instead of multiple rounds of binding and 
amplification, one round of selection is sufficient to capture relative binding affinities as 
fold enrichments of sequenced DNA fragments. However, deriving binding motifs and 
relative affinities involves the use of probabilistic computational approaches and 
therewith attached caveats [38].  TF throughput of SELEX based methods currently 
remains limited as sufficient protein needs to be purified and the handling steps have not 
yet been adapted to high-throughput (Table 1). Nevertheless SELEX-seq may prove to 
be a more cost-effective, comprehensive and higher-throughput alternative to protein 
binding microarrays (PBMs) in the near future [39].
With the availability of DNA microarray chips, binding reactions can be 
performed on immobilized double-stranded DNA oligonucleotide arrays (Figure 2B)
[28-32]. In short, a protein of interest is allowed to bind to a protein binding microarray. 
Following stringent washing steps, binding events are quantified by immuno-detection 
using protein specific, fluorophore coupled antibodies. Signal intensities are analyzed 
and interpreted as differential binding profiles. Recent advances in the field of 
microarray technology allow the fabrication of high-density arrays, harboring practically 
all permutations of a 10-mer sequence. On a 44’000 feature array all ~1’000’000 
features of a 10mer space are represented as a nested de Bruijn sequence [28].  Cognate 
Site Identifier arrays (CSI) based on single stranded oligos that fold over to form 
dsDNA hairpins have up to 1’000’000 unique features and therefore do not need to rely 
on de Brujin sequences [31, 32]. Using such “universal” PBMs not only increased the 
resolution by which binding motifs are detected, but also enabled the use of a single 
microarray design to examine a broad range of TFs [28]. The information obtained from 
PBMs is generally significantly reduced into the form of position weight matrices based 
on the additivity assumption, which posists that bases contribute independently to the 
binding (PWMs; Figure 4AB). Calculating relative binding affinities by the mere sum 
of individual base contacts is an oversimplification and often leads to overestimation of 
binding strength (Figure 4CD). Recently, Carlson et al. have proposed a visualization 
method to omit this information reduction. The display of all the information obtained 
from PBMs highlights the context dependencies of TF binding [31].
DNA immunoprecipitation (DIP-chip)[40] is another in vitro approach, 
conceptually intermediate between in vitro selection (SELEX) and immunoprecipitation 
of in vivo cross-linked chromatin (ChIP, see following section; Figure 2C). Instead of 
synthesized DNA oligos, purified chromosomal DNA is used in binding reactions. 
Binding complexes are fixed by cross-linking with formaldehyde, sheared into shorter 
fragments between 100-500 base pairs, and immunoprecipitated with a protein-specific 
antibody. After reversal of the cross-links, enriched DNA fragments are analyzed by 
microarrays. Binding site discovery is limited by the inherently low experimental 
resolution due to sheared fragment size.
Until recently only methods with relatively low-throughput were available to 
measure the quantitative parameters of protein-DNA interactions, namely surface 
plasma resonance platforms, like BIAcore [41, 42], and classical gel shift assays 
(EMSA)[17, 18]. This experimental gap has recently been filled by the development of 
a high-throughput microfluidics platform, which employs a novel detection method 
based on the mechanically induced trapping of molecular interactions (MITOMI; Figure 
3)[9]. MITOMI devices, as well as detailed information on how to set up a valve 
control interface can be readily obtained from the Stanford Microfluidics Foundry 
(http://thebigone.stanford.edu/foundry/) and the Caltech Foundry (http://kni.caltech.edu/
foundry/). In short, microfluidic chips are fabricated by multilayer soft lithography and 
aligned to an epoxy-coated glass slide containing thousands of micro-arrayed DNA 
spots using standard DNA microarray printing instrumentation [9, 43, 44]. Here, each 
spot codes for a different DNA sequence or concentration, separated and controlled in 
pL sized reaction chambers. The concentration-dependent binding to an immobilized TF 
across the whole chip, and thus hundreds of variable DNA sequences, enables the 
measurement of thousands of interactions in a single experiment. MITOMI can detect 
transient and low affinity interactions that are usually missed by other techniques due to 
the need of stringent wash steps. Indeed mechanical trapping of the interacting 
molecules completely eliminates loss of molecules and the consequent skew of the 
apparent affinity before the measurement. Therefore, combined with DNA 
concentration standards, absolute binding affinities (dissociation constants Kd) can 
readily be obtained in the nM to µM range. 
The same strategy can be used in a reverse configuration by programming 
reaction chambers with linear templates for cell-free in vitro expression of hundreds of 
TFs [10, 34]. In this scenario one+can+either+test+a+promoter+fragment+of+interest+for+binding+to+hundreds+of+TFs,+or+one+can+even+search+for+interactions+between+TFs+and+coHregulators. As previously mentioned, the precise and quantitative 
characterization of TF-DNA, and TF - co-regulator interactions is fundamental to our 
understanding of transcriptional regulation, since realistic, quantitative modeling of 
transcriptional regulation relies on these types of data [45].
So far, most TF-DNA binding studies focused on measuring binding affinities 
of a given TF to a range of DNA sequences. Only a few studies considered the reverse 
direction by designing TFs with specific DNA-recognition properties [46]. Yet these 
types of studies promise to provide us with a better understanding of how transcription 
factors recognize DNA and how this recognition could have evolved. Combining on-
chip protein synthesis and MITOMI affinity measurement have recently made such 
permutation studies recently feasible. The DNA-binding repertoire of 95 TF mutants of 
a member of the basic Helix-Loop-Helix family [2] has recently been characterized 
using such an approach [10]. In this study each of the 19 possible aa point substitutions 
of five residues known to form DNA base-specific contacts have been tested for 
binding against 64 DNA sequences. This systematic characterization shed light on the 
functional significance of each residue and the consequence of mutations, and thus can 
help build an understanding of how transcription factor diversity arose.
In vitro measurements of transcription factors are well suited for discovering 
consensus sites and binding preferences, as well as for providing a quantitative 
foundation of transcription factor function. In combination with complete genome 
sequences, in vitro characterization of TF binding preferences enables us to map the 
genome-wide distribution of TFBS and discover candidate target genes in silico [9, 47, 
48]. However, a given TF might not always regulate all targeted genes at the same time, 
or in all cell types, due to cell line-specific modulation of TF activity by co-regulators. 
In such cases relating in vitro determined binding preferences with in vivo measured 
protein occupancy profiles is indispensable.
Most in vitro and in vivo experimental approaches rely on a computational 
framework to detect binding sites [38]. Amongst those MEME, AlignACE, and 
MDscan are the most commonly used programs to find sequence elements conserved in 
a set of DNA sequences [49-51]. Although computational techniques for binding site 
detection have greatly improved over the past years, the underlying assumptions often 
oversimplify TF-DNA interactions, which commonly results in a high rate of false-
positive predictions [11, 13, 38, 52, 53]. Finally, the quantitative modeling of GRN not 
only relies on estimated TF binding affinities, but also on the assumption that TFs bind 
their targets under equilibrium conditions in vivo [12, 54, 55]. Considering the time 
scale of transcriptional responses under induced stress, this assumption is likely an 
oversimplification. To circumvent this, one needs to consider the kinetics of binding 
events. To date only low-throughput approaches, like the SPR BIAcore platform, allow 
the reliable measurement of TF-binding kinetics. Recently it has been shown that, in 
principle, MITOMI can be utilized to measure binding kinetics at a higher throughput 
[56].
In vivo methods
The most commonly used in vivo method to probe for genome-wide TF binding is 
based on chromatin immunoprecipitation (ChIP; Figure 2C)[57] integrated with either 
DNA microarray technology (ChIP-chip)[20, 21, 24] or more recently with massive 
parallel sequencing (ChIP-seq)[22, 25]. Similar to the previously mentioned DIP-chip 
experiments, TF-DNA complexes are fixed in situ by cross-linking with formaldehyde, 
sheared into pieces with average length of 100-500 base pairs, and precipitated from 
solution using a TF-specific antibody. The enriched DNA is quantified after reversal of 
the cross-links by either hybridization to DNA microarrays or deep sequencing. In 
general, both ChIP-chip and ChIP-seq offer a tremendous throughput in profiling 
genome-wide protein occupancies (Figure 1); while in direct comparison to ChIP-chip, 
ChIP-seq has improved resolution, lower noise levels, and a higher dynamic range [25]. 
However, throughput for both ChIP-based methods is limited by the fact that 
experimental feasibility is strongly dependent on: (i) protein abundance, (ii) cross-
linking efficiency, and (iii) antibody availability and specificity [25]. Finally, to identify 
potential binding sites raw ChIP data needs to be processed with computational 
techniques, which might remain unsatisfactory as the distinction of direct and indirect 
protein-DNA interactions are problematic (Figure 2C, see e.g. comparison between 
ChIP and DIP)[58]. 
Recently, the use of ChIP-seq experiments across several humans elucidated the 
impact of genetic variation in TFBS between individuals on TF occupancy [6]. 
Interestingly, the same study could show that genomic loci with strong ChIP-seq signal, 
and thus high TF occupancy, are also more frequently occupied in chimpanzee than 
weaker signals, pointing towards a divergence of weaker, low-affinity binding sites. 
The importance of low-affinity TF binding in coordinating transcriptional regulation has 
already been proposed in previous studies [59]. In direct agreement the quantitative 
variation of TFBS occupancy between closely related Drosophila species have been 
attributed to modest levels of sequence divergence of otherwise highly conserved 
binding motifs [60]. However, it remains to be evaluated to what extent these variations 
translate into alternative transcriptional and developmental programs [60]. Both, the 
widespread functionality of weak TFBS [59], and the apparent evolutionary divergence 
of quantitative TFBS traits [60] point towards the necessity to capture minute 
differences amongst binding sites across a broad affinity regime. 
Instead of cross-linking and immunoprecipitation of proteins with DNA, the 
protein of interest can be fused to Escherichia coli DNA adenine methyltransferase 
(DamID)[61]. Upon binding to DNA, nucleotides in close vicinity of TF binding are 
methylated. The methylated DNA is then immunoprecipitated and analyzed by either 
microarrays or sequencing approaches. Since methylation is restricted to adenine in 
GATC sites, the resolution of binding site mapping is limited by the distance between 
two consecutive such sites. This bias in resolution is omitted in approaches that use 
micrococcal nuclease fusion proteins. In chromatin endogenous cleavage (ChEC) TF-
tagged with micrococcal nuclease is activated in vivo by rising levels of Ca2+ [62]. 
Binding events are detected by mapping of induced double-strand DNA breaks. So far 
ChEC has not been integrated to high-throughput readouts by deep sequencing or 
microarray approaches.
A different approach is reverse ChIP or proteomics of isolated chromatin 
segments (PICh), which is an alternative method for identifying TFs bound to a given 
locus. Briefly, following a cross-linking step, a desthiobiotin conjugated DNA probe is 
used to hybridize to a specific genomic locus, and associated proteins are isolated and 
analyzed by mass spectrometry [63]. This approach alone does not discriminate whether 
identified proteins are TFs that bind directly or indirectly to DNA. Also, the general 
applicability of PICh remains to be evaluated, not least because probe design and mass 
spectrometric analysis will need refinement to adapt to a high-throughput setting.
None of the above-mentioned methods is unbiased with regard to the TF or 
DNA segment under investigation. DNaseI hypersensitivity assays offer an unbiased, 
genome-wide mapping of protein binding in vivo when integrated with microarray or 
massive parallel sequencing [64-66]. The degree of chromatin DNaseI sensitivity 
allows for the distinction between nucleosome bound and unbound genomic loci. An 
alternative approach is the use of ChIP based methods to profile genome-wide histone 
modifications. In this case the detection of alternative chromatin structure can be used to 
profile genomic regions accessible to TFs [67]. Whether unbound genomic regions are 
due to the binding of regulatory proteins remains to be validated experimentally or 
analyzed computationally by considering known TF binding preferences.
One of the first ChIP-chip experiments revealed that many in silico predicted 
binding sites are not occupied in vivo [23]. Thus, in addition to the precision of in vitro 
approaches in determining TF binding preferences, an in vivo viewpoint is necessary to 
distinguish between biologically functional and non-functional sites. The prediction of 
in vivo binding sites from in vitro derived TF binding preferences is still far from being 
accurate. One reason is the lack of detailed knowledge of the combinatorial interaction 
between TFs, cofactor proteins, and chromatin modifiers [68, 69]. Ravasi et al. have 
recently addressed this issue by combining mammalian two-hybrid screens with gene 
expression studies [69]. Their analysis highlighted the importance of TF-TF interactions 
to establish precise transcriptional programs during developmental processes. Solely 
considering TF-DNA interactions would have missed this regulatory network. On the 
other hand the identification of TF binding sites by in vivo experimental methods suffers 
from drawbacks in (i) the resolution by which binding site can be identified, (ii) the lack 
to distinguish between direct and indirect interactions, (iii) that the observed interactions 
are context dependent, and (iv) the fact that only qualitative, or at best semi-quantitative, 
data can be obtained.
Consolidation of in vivo and in vitro approaches
Recent technological advances in both, in vitro as well as in vivo methods, have 
greatly improved our ability to study TF-DNA binding specificity on a comprehensive 
level. However, no single approach provides sufficient information to reliably predict 
the quantitative behavior of gene regulation. While in vitro methods are indispensable 
for the biophysical characterization and quantification of protein-protein and protein-
DNA interactions, it is still difficult to translate this information into actual in vivo 
function. In many cases only a fraction of high-affinity TFBS are occupied in vivo [23], 
pointing to secondary effects like the masking of binding sites by competing TFs, 
nucleosomes [70, 71] or the existence of cooperative binding events frequently missed 
by in vitro approaches [71]. It will be an exciting endeavor to evaluated the extent to 
which the consolidation of multiple in vitro data sets, including reconstituted 
nucleosome occupancy maps and TF-TF interactions, will reduce the discrepancy 
between in vitro and in vivo results [54, 72]. On the other hand, in vivo methods have 
the advantage of profiling biologically relevant protein-DNA interactions (e.g. ChIP-
seq), albeit, at the expense of being inconclusive with regard to the underlying binding 
causalities (direct vs. indirect binding). A significant fraction of ChIP signals often 
cannot be correlated to a corresponding TFBS, even in cases where a TF is known to 
directly bind to DNA [73]. In the near term only a consolidated view of both, in vivo as 
well as in vitro results promises the unambiguous identification and characterization of 
TF-DNA interactions. 
While in vivo approaches differ with regard to resolution, “ChIP-chip vs ChIP-
seq”, and experimental bias, “TF-centered vs. unbiased DNaseI sensitivity” (Table 1), 
in vitro approaches greatly differ with regard to throughput and information content 
(Figure 1 and Table 1). Even without a priori knowledge of possible sequence 
specificity, in vitro selection and PBM approaches offer de novo TFBS identification. 
Throughput is limited in principle by the fact that proteins need to be purified to 
sufficient grade and amounts (Table 1). However, both methods suffer from the 
inability to account for sequence specific TF dissociation rates. Prior to readout, bound 
fractions need to be selected and thus washed under stringent conditions. This results in 
sequence-specific dissociation of TF-DNA complexes, the rates of which are non-
linear, unknown and probably vary with sequence (in fact it is probably the dissociation 
rate that dominates affinity). This results in overestimation of high-affinity binders and 
thus returns skewed binding profiles. Neither in vitro selection nor PBM approaches 
can provide quantitative information on affinity and kinetics of the interactions. 
MITOMI based methods, on the other hand, allow absolute binding affinity 
measurement of at medium throughput but are not suited for de novo identification of 
TFBS. The best experimental strategy would be a serial combination of methods with 
different throughput and information content (Figure 1, Table 1). Initial consensus and 
PWM discovery is optimally done with ChIP, HT-SELEX, or PBM approaches. This 
initial discovery-oriented approach can then be followed up with a MITOMI analysis to 
arrive at quantitative binding information and a controlled environment for higher-order 
interaction measurements. Indeed as the catalogues of transcription factor consensus 
sites and PWMs is growing [74-76], quantitative measurements and their integration 
with in vivo data are becoming more and more important.
Transcription factor characterization has come a long way in the last decade, 
with the advent of a multitude of powerful and for the most part mutually 
complementary methods. Consensus site and binding preferences can now be routinely 
measured both in vivo and in vitro and precise quantitative measurements can be 
performed using new methods based on microfluidics, interrogating both the DNA 
sequence space as well as the protein space. Yet, the challenge remains the same: 
developing a quantitative understanding of gene regulatory networks. Ultimately, the 
most universal model would only rely on biophysical measurements of transcription 
factors and co-factors as these are context-independent and therefore need only be 
measured once but may be applied universally. Developing hybrid solutions, which take 
into account in vivo and in vitro measurements are more within our reach. Indeed, any 
model must be validated with comprehensive in vivo measurements, including ChIP-
based binding profiles integrated with expression and proteomic data.
Key points
1) The connectivity of gene regulatory networks (GRNs) as well as the quantitative 
level of gene expression is determined by the specific binding of transcription factors to 
cognate binding sites. Moderate genetic variations in these binding sites can lead to 
quantitative differences in TF occupancies and potential differences in transcriptional 
output. It is pivotal to our understanding of transcriptional regulation to precisely 
characterize the quantitative nature of TF-DNA interactions.
2) TF-DNA interactions can be experimentally characterized by two fundamentally 
different approaches: in vivo- and in vitro-based methods. In vivo-based methods 
recover information on the TF consensus binding sites as well as the biological context 
of DNA specific interactions. In vitro methods aim to identify TF consensus binding 
sites, binding energy landscapes or the biophysical parameters governing these binding 
events, and thus can be further subdivided into methods that provide qualitative or 
quantitative data.
3) A serial combination of methods with different throughput and information content 
generally constitutes the best experimental strategy to study TF-DNA interactions: (i) 
ChIP, HT-SELEX, or PBM approaches to derive consensus sequences and PWM. (ii) 
MITOMI analysis to substantiate PWM data with quantitative binding information. (iii) 
Cross-comparison of in vitro binding data with in vivo binding profiles derived from 
ChIP experiments.
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Figure legends
Figure 1: Comparison of target DNA throughput and information content of selected 
methods. In vivo-based methods (highlighted in red), offer tremendous throughput but 
low information content. In vitro-based methods, while decreasing throughput, increase 
information content. MITOMI can be in principle be extended to collect kinetic 
information, as indicated by the dotted extension.
Figure 2: Experimental flow chart of TF-DNA characterization. (A) In vitro selection of 
TF binding sites consists of several rounds of binding and amplification of captured 
dsDNA targets. Captured targets are either analyzed individually by cloning and 
sequencing or in bulk by deep sequencing approaches. (B) Protein binding microarray 
consist of micro-arrayed dsDNA oligos. A binding reaction is performed by 
hybridization of TF to these microarrays. Following a wash step, bound TFs are 
immunodetected by a TF specific, fluorscent antibody. (C) Immunoprecipitation based 
approaches consist of cross-linking TFs to genomic loci in vivo (ChIP) or in vitro 
(DIP), followed by shearing of DNA and precipitation with a TF specific antibody. 
Enriched DNA fragment are analyzed after reversal of cross-linking by microarray or 
deep sequencing. Lined and solid arrows highlight key steps for ChIP and DIP 
approaches, respectively and the numbers in the arrows indicate the sequence of 
experimental steps. Note the difference between ChIP and DIP approaches with regard 
to masked, direct, and indirect binding events.
Figure 3: Experimental flow chart of mechanically induced trapping of molecular 
interactions (MITOMI). (A) Device setup. Target DNAs are spotted on a glass 
substrate and aligned to DNA chambers of the PDMS chip. One valve separates the 
DNA chamber from the detection area. TFs are immobilized by selective pull-down 
underneath the trap. Flanking valves separate unit cells. (B, C) A binding reaction is 
initiated after opening of DNA chamber valves, and diffusion of target DNA to 
detection area. Equilibrium bound fraction is separated from unbound fraction by 
mechanical trap and washing step. From left to right: Top view of unit cell, fluorescence 
image of diffused fluorescence tagged target DNA, and side view of detection area. (D) 
Binding affinity constants are determined by non-linear regression fitting of the 
saturation-binding curve obtained from the measurements.
Figure 4: Summary of transcription factor binding site representation. (A) TF binding 
site preferences are detected as enrichment of TF-bound DNA fragments by massive 
parallel sequencing or microarray approaches. (B) Sequence counts or microarray-based 
relative fluorescence units (RFU) are transformed into position-specific weight matrix 
(PWM) by counting base frequencies of selected DNA sequences. PWMs are 
commonly represented as sequence logos. (C, D) PWM predicted binding affinities of 
sequences with multiple base deviations relative to consensus binding site commonly 
overestimate affinity changes due to assumption of base independence.




Synonyms Throughput Material Resolution References
(DNA sequence space) neededc
In vitro approaches
Selection of target SELEX, CASTing >200000 sites mg of P + consensus site few high affinity binding sites
Tuerk and Gold (1990); Wright et al. 
(1991)
Selection of target coupled to 
NGS
HT-SELEX, Bind-n-Seq >200000 sites mg of P ++ PWMa Nucleotide resolution feasible
Zykovich et al. (2009); Zhao et al. 
(2009)
Protein binding microarray PBM, CSI up to 1 milion sites mg of P ++ PWMa Nucleotide resolution feasible
Mukherjee et al. (2004); Warren et 
al. (2006)
DNA immunoprecipitation DIP-chip all genomic sites µg of P + PWMa between 100 and 500bp Liu et al. (2005)
Mechanical trapping MITOMI 1000 to 100 sites ng of P +++(+) absolute KD (kon, koff) Nucleotide resolution Maerkl and Quake (2007)
Gel shift EMSA around 10 sites mg of P ++++ absolute KD, kon, koff few binding sites only Fried and Crothers (1981)
Surface plasma resonance BIAcore up to 100 site µg of P ++++ absolute KD, kon, koff few binding sites only Fägerstam et al. (1992)
In vivo approaches
ChIP coupled to microarray ChIP-chip all genomic sites ng of D + PWMa,b between 100 and 500bp Ren et al. (2000)
ChIP coupled to NGS ChIP-seq all genomic sites ng of D + PWMa,b between 100 and 500bp Johnson et al. (2007)
TF mediated DNA methylation 
profiling
DamID all genomic sites ng of D + PWMa between 100 and 500bp Steensel and Henikoff (2000)
reverse ChIP PICh one genomic site * - Dejardin and Kingston (2009)
DNaseI sensitivity profiling 
coupled to NGS
DNaseI-seq all genomic sites ng of D + PWMa Nucleotide resolution feasible Hesselberth et al. (2009)
a qualitative to semi-quantitative
b no distinction between direct/indirect interaction
c protein (P); genomic DNA (D)
* picomole of each protein; MS detection limit 
Data type
Table 1. Comparision of in vitro- and in vivo-based methods to characterize transcription factor binding specificities.
